Table 2.
BSP | Duration | Peak-to-peak Amplitude | Power | |||
---|---|---|---|---|---|---|
Burst | Suppressions | Burst | Suppressions | Burst | Suppressions | |
0.3–0.4 | 1.79 s (95% CI: 1.33–2.27 s) | 0.76 s (95% CI: 0.41–1.29 s) | 349.77 μV (95% CI: 322.16–386.61 μV) | 90.09 μV (95% CI: 74.04–107.76 μV) | 65.82 dB μV2/s (95% CI: 65.37–66.30 dB μV2/s) | 56.14 dB μV2/s (95% CI: 55.00–57.24 dB μV2/s) |
0.4–0.5 | 1.76 s (95% CI: 1.27–2.11 s) | 1.14 s (95% CI: 0.41–1.46 ss) | 378.46 μV (95% CI: 347.70–407.31 μV) | 94.20 μV (95% CI: 80.06–109.29 μV) | 66.09 dB μV2/s (95% CI: 65.59–66.57 dB μV2/s) | 55.24 dB μV2/s (95% CI: 54.63–56.33 dB μV2/s) |
0.5–0.6 | 1.68 s (95% CI: 1.29–2.8 s) | 1.79 s (95% CI: 1.06–2.66 s) | 571.07 μV (95% CI: 506.36–601.20 μV) | 84.20 μV (95% CI: 72.80–102.86 μV) | 67.88 dB μV2/s (95% CI: 67.34–68.23 dB μV2/s) | 53.89 dB μV2/s (95% CI: 52.97–54.89 dB μV2/s) |
0.6–0.7 | 1.55 s (95% CI: 1.28–1.76 s) | 2.73 s (95% CI: 2.16–3.53 s) | 587.73 μV (95% CI: 553.49–646.48 μV) | 97.86 μV (95% CI: 89.80–105.98 μV) | 68.46 dB μV2/s (95% CI: 68.07–68.65 dB μV2/s) | 53.99 dB μV2/s (95% CI: 53.50–54.45 dB μV2/s) |
0.7–0.8 | 1.26 s (95% CI: 1.02–1.47 s) | 3.46 s (95% CI: 2.69–4.36 s) | 305.02 μV (95% CI: 274.58–334.39 μV) | 93.75 μV (95% CI: 85.85–102.54 μV) | 64.07 dB μV2/s (95% CI: 63.63–64.72 dB μV2/s) | 53.65 dB μV2/s (95% CI: 52.71–54.02 dB μV2/s) |
95% confidence intervals around the differences indicate if there is a significant increase, decrease, or no change between the two anesthetics. Sevoflurane-induced bursts and suppressions are significantly greater in magnitude than propofol-induced bursts and suppressions across all BSP values for duration, peak-to-peak amplitude, and power.